Articles by Jennifer Markarian - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Jennifer Markarian

Pfizer Settles Patent Litigation with Mylan

Sep 11, 2012

Pfizer and Mylan have agreed on terms by which Mylan may launch its generic version of Pfizer's Detrol LA (tolterodine tartrate) extended-release capsules, pending final approval by FDA.

The Foundation for the National Institute of Health Seeks Public Comment

Aug 28, 2012

The Observational Medical Outcomes Partnership (OMOP), which is managed by the Foundation, desires feedback on proposed research priorities and tasks.

Waste Management of Disposable Biopharmaceutical-Manufacturing Components

Aug 15, 2012

Recycling is becoming a viable option for disposal of single-use systems.

Pfizer's Zoetis Subsidiary Files IPO

Aug 14, 2012

Zoetis, a subsidiary of Pfizer, filed a registration statement with the US Securities and Exchange Commission for a potential initial public offering of Class A common stock.

Second-Quarter 2012 Financial Reports Show Pfizer, Novartis Down; Merck Up

Jul 31, 2012

Pharmaceutical industry leaders Pfizer, Novartis, Merck, and other companies released second-quarter 2012 results, emphasizing growth of new products and strength in emerging markets.

Defining Design Space in Hot-Melt Extrusion

Continuous manufacturing of amorphous solid dispersions in a twin-screw extruder is well-suited to quality by design processes such as defining design space.
Jul 18, 2012

Continuous manufacturing of amorphous solid dispersions in a twin-screw extruder is well-suited to quality by design processes such as defining design space.

IMS Institute for Healthcare Informatics Issues Forecast for Global Medicine Use

Jul 16, 2012

Global spending on medicines is estimated to reach nearly $1.2 trillion by 2016.

ISPE Issues Guidance for Packaging, Labeling, and Warehousing Facilities

Jul 9, 2012

ISPE has issued a guidance that is intended to help companies meet cGMP requirements for packaging, labeling, and warehousing facilities and avoid problems such as product adulteration, product mix-up, label mix-up, and misbranding.

Hot-Melt Developments

Developments in hot-melt extrusion using twin-screw extruders to make solid-dosage drug forms.
Jul 2, 2012

Developments in hot-melt extrusion using twin-screw extruders to make solid-dosage drug forms.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
FindPharma Custom Search
Click here